本报讯 （记者毛艺融）近日，上交所举办第六期未来产业沙龙，主题为"脑机接口：探索数字化智慧时 代"。6家上市公司、12家脑机接口产业链企业出席，还有12家商业银行、证券公司、创投等金融机构到 场。 会上，各方通过主题演讲、分组交流等形式，热议脑机接口技术路线、商业化应用、支付方式和行业监 管等话题。 上交所有关负责人表示，目前，上交所正在按照证监会统一部署，加快推动科创板改革"1+6"政策落地 见效，提升资本市场对科技创新的包容性和适应性。下一步，上交所将深入开展"三开门"专项行动，携 手各方同向发力，让资本市场改革举措与产业政策形成合力，打造多元化资本工具矩阵，为优质科技企 业提供全生命周期、全产品线、全业务链条培育和服务，促进新质生产力发展再上新台阶。 产业政策架桥开道 脑机接口是在大脑与外部设备之间创建信息通道，实现直接信息交互的新型交叉技术，已形成侵入式和 非侵入式两大技术路线。脑机接口应用领域广泛，涵盖医疗健康、教育、消费、智能驾驶等，市场估计 其潜在市场空间超过千亿美元。 2025年7月份，工业和信息化部等七部门联合发布的《关于推动脑机接口产业创新发展的实施意见》明 确提出，到2027年，脑机接口 ...

上交所有关负责人表示，下一步，上交所将深入开展"三开门"专项行动，携手各方同向发力，让资本市 场改革举措与产业政策形成合力，打造多元化资本工具矩阵，为优质科技企业提供全生命周期、全产品 线、全业务链条培育和服务，促进新质生产力发展再上新台阶。 从技术目标看，脑机接口需要在人脑与机器之间打造可交互的"信息闭环"。与会企业认为，非侵入式和 侵入式两类路线在不同应用场景各擅胜场。非侵入式脑机接口产品具备可穿戴性，安全性高；侵入式脑 机接口产品在精准控制、临床医疗方面具有优势，但因涉及电极植入人脑，在生物相容性、长期稳定性 和微创手术技术方面仍有瓶颈。有企业认为，推动医疗监管政策与技术研发同步迭代，将是侵入式脑机 接口产业化的关键一步。还有企业称，在脑电信号的高精度采集与实时解码方面，还需要进一步推动算 法、芯片及材料技术融合创新，共同打造从芯片、算法到临床应用的完整生态；未来，非侵入式和侵入 式两大技术路线亦有可能相互融合，形成互补式的创新产品。 将脑机接口从"信息闭环"推向"商业闭环"也是相关企业的一项长期课题。与会企业认为，脑机接口产业 化应用要经过实验室开发、临床试验和监管审批三道关。从目前的临床研发进程来看 ...

Group 1 - The core point of the news is that Daoshi Technology announced an investment in Qiangnao Technology, acquiring minority shareholder rights through a $30 million investment in Pre-B round preferred shares [1][2] - Following the announcement, Daoshi Technology's stock surged over 15%, with its market capitalization exceeding 18 billion yuan [2] - The investment aims to leverage Qiangnao Technology's expertise in brain-computer interface technology to enhance Daoshi Technology's capabilities in the "AI + new materials" ecosystem and accelerate the application of carbon material products in key components like electronic skin [2][3] Group 2 - Qiangnao Technology, a leading brain-computer interface company, is rumored to be pursuing financing with a valuation exceeding $1.3 billion, and its IPO process is highly anticipated [3] - Daoshi Technology has established a multi-faceted strategy in the "AI + new materials" sector, including a joint venture with Chipenson to create the Guangdong Hexi Atomic Computing Center, which is expected to be completed by the end of the year [3] - Financially, Daoshi Technology reported a revenue of 7.752 billion yuan in 2024, a year-on-year increase of 6.25%, and a net profit of 157 million yuan, marking a return to profitability [3]

Core Viewpoint - Daoshi Technology plans to invest $30 million in Brain Family Inc. as part of its "AI + Materials" strategy, aiming to integrate new material technologies with cutting-edge brain-computer interface applications [1] Group 1: Investment Details - Daoshi Technology's subsidiary, Hong Kong Jiana, will use its own funds to subscribe to preferred shares in Brain Family Inc. during its Pre-B round [1] - The investment agreement has been signed, but completion is subject to approval by Brain Family's board and specific shareholders [1] Group 2: Strategic Intent - The investment aligns with Daoshi Technology's core strategy of combining AI with materials, focusing on applications in humanoid robots and high-end medical devices [1][2] - Daoshi Technology possesses core technology reserves in graphene, carbon nanotubes, and other carbon-based materials, which are ideal for creating electronic skin, flexible sensors, and artificial muscles [2] Group 3: Market Potential and Trends - Brain Family Inc. specializes in non-invasive brain-computer interface technology, which is safer and more cost-effective than invasive methods, making it suitable for consumer and rehabilitation markets [2] - The collaboration is expected to accelerate the development and market expansion of Daoshi Technology's carbon material products in key components for humanoid robots [3] - The brain-computer interface industry is transitioning from a research-driven model to a clinically driven one, with increasing establishment of clinical wards and research platforms [3]

Core Viewpoint - Daos Technology announced a significant investment in Strong Brain Technology through its subsidiary Hong Kong Jiana, aiming to enhance its capabilities in AI and new materials applications [1] Investment Details - Hong Kong Jiana will invest $30 million to acquire preferred shares in Strong Brain Technology, gaining minority shareholder rights [1] - The transaction is subject to approval by Strong Brain Technology's board and specific shareholders [1] Strategic Goals - The investment aims to leverage Strong Brain Technology's expertise in brain-computer interface applications across medical rehabilitation, educational consumption, and human-computer interaction [1] - The company intends to enhance its "AI + new materials" ecosystem and accelerate the application of carbon material products in key components like electronic skin [1]

Core Insights - Strong Brain Technology's bionic hand is one of the few mass-produced prosthetics that allows users to control each finger through neural electrical signals without invasive surgery [1] - The non-invasive brain-computer interface (BCI) technology is gaining attention due to its higher safety and accessibility potential, marking a critical phase of transitioning from laboratory to commercialization [1][3] - Dao's Technology announced a $30 million investment in Strong Brain Technology's Pre-B round preferred shares, aiming to leverage its experience in materials to create an "AI + materials" platform [1] Company Developments - Strong Brain Technology aims to empower individuals with disabilities by providing bionic prosthetics that enable them to perform daily tasks such as grasping objects and walking [1][2] - The company has successfully mass-produced bionic prosthetics that enhance user experience, including a bionic leg that provides a natural walking experience and reduces the risk of falling [1][2] - Strong Brain Technology has become a leading supplier of dexterous hands for humanoid robots, capitalizing on its technological advancements in bionic hands [2] Technological Innovations - The company has made significant advancements in reading and interpreting weak human electrical signals, which are crucial for controlling bionic limbs [2] - Innovations in materials science and AI algorithms have enabled the company to capture and process these signals more effectively, simplifying the user experience [2][3] - The integration of AI in non-invasive BCI technology has accelerated industry growth, allowing for better extraction of relevant information from complex signals [3] Consumer Focus - Strong Brain Technology emphasizes the importance of understanding consumer needs to fulfill its vision of "unlocking more possibilities in life" [3] - The company aims to develop the next generation of bionic limbs that allow for bidirectional interaction, enabling users to sense external conditions [3] - Despite reducing the price of bionic limbs to one-fifth to one-tenth of European brands, the cost remains a burden for many disabled individuals [3][4] Social Responsibility - The company collaborates with local disability associations and charitable organizations to provide free bionic hands and legs to eligible individuals [4] - A project initiated by the Zhejiang Provincial Disabled Persons Welfare Foundation has already benefited 400 individuals, with plans to assist 2,000 more this year [4]

Core Insights - Strong Brain Technology's bionic hand is one of the few mass-produced prosthetics that allows users to control each finger through neural electrical signals without invasive surgery [1][2] - The non-invasive brain-computer interface (BCI) technology is gaining attention due to its higher safety and accessibility potential, marking a critical phase of transitioning from laboratory to commercialization [1][5] Group 1: Product and Technology - The bionic prosthetics produced by Strong Brain Technology enable users to perform daily tasks such as grasping objects, writing, and playing instruments [2] - The company has made significant advancements in signal collection, allowing users to control the bionic hand with minimal delay after a brief signal collection process [2][3] - Strong Brain Technology has become a leading supplier of dexterous hands for humanoid robots, leveraging its experience in bionic hands to address engineering challenges in robotics [3] Group 2: Innovation and Development - The company has achieved breakthroughs in materials science and AI algorithms, enhancing the sensitivity and stability of signal capture without the need for conductive gel on the skin [3][4] - AI algorithms play a crucial role in the development of non-invasive BCI technology, enabling the extraction of relevant information from complex and noisy signals [4] Group 3: Market and Social Impact - Strong Brain Technology aims to make bionic prosthetics more affordable, reducing prices to one-fifth to one-tenth of European brands, yet still recognizes the financial burden on many disabled individuals [5] - The company collaborates with local disability organizations and foundations to provide free bionic hands and legs to eligible individuals, with a goal to assist 2,000 disabled people in Zhejiang this year [5][6]

Core Viewpoint - Daoshi Technology announced an investment of $30 million in Brain Family Inc. to acquire minority shareholder rights, aiming to enhance its capabilities in the "AI + materials" strategy [1][4]. Group 1: Investment and Strategic Partnership - Daoshi Technology's subsidiary, Hong Kong Jiana, signed a Pre-B round preferred stock subscription agreement with Brain Family Inc. [1] - The investment will be finalized after approval from Brain Family's board and specific shareholders [1]. - The collaboration focuses on leveraging Brain Family's expertise in non-invasive brain-machine interface technology for applications in medical rehabilitation, educational technology, and human-computer interaction [4]. Group 2: Market Potential and Product Development - The global market for single-walled carbon nanotube conductive slurry is projected to grow from approximately 1.6 billion yuan in 2024 to 17.8 billion yuan by 2030 [4]. - Daoshi Technology plans to redirect 300 million yuan of unallocated fundraising to a project aimed at producing 120 tons of single-walled carbon nanotubes annually [4]. Group 3: Financial Performance - In the first half of 2025, Daoshi Technology reported a revenue of 3.65 billion yuan, a decrease of 11.64% year-on-year, while net profit attributable to shareholders increased by 108.16% to 230 million yuan [6][8]. - Research and development expenses saw a significant decline of 41.39% compared to the previous year, primarily due to reduced direct material inputs and personnel costs [8]. Group 4: Technological Advancements - Daoshi Technology has achieved breakthroughs in the mass production of advanced carbon materials, including carbon nanotubes and graphene, which are essential for Brain Family's smart bionic limbs that require high-sensitivity and biocompatible electrode materials [5][9]. - The company is advancing its capabilities in the lithium battery and carbon material supply chains, focusing on integrating research and production platforms for new materials [8].

每经记者｜朱成祥 每经编辑｜张益铭 丨2025年9月3日 星期三丨 NO.1 晶澳科技：拟回购2亿元至4亿元公司股份 9月2日，晶澳科技公告称，拟回购不低于2亿元且不超过4亿元公司发行的人民币普通股（A股），回购 价格不超过17.36元/股。回购的股份将在未来适宜时机全部用于员工持股计划或者股权激励。回购期限 为自董事会审议通过本次回购方案之日起12个月内。 9月2日，滨海能源公告称，股东王建林及其一致行动人于2025年7月19日至9月1日期间，王建林以集中 竞价交易方式减持公司股份212.42万股，占公司总股本的0.96%。本次减持后，王建林及其一致行动人 合计持股比例降至7.95%，变动触及1%刻度的整数倍。此次减持不会导致公司控股股东、实际控制人发 生变化，也不会影响公司的治理结构和持续经营。 点评：滨海能源股东王建林及其一致行动人的减持行为，虽然涉及股份比例不大，但仍需关注其对市场 情绪的潜在影响。减持后，持股比例降至7.95%，虽未改变公司控制权结构，但投资者可能对公司未来 发展产生疑虑。公司应加强信息披露，保持透明度，以稳定市场预期，维护投资者信心。 NO.3 道氏技术：香港佳纳出资3000万美元 ...

Core Viewpoint - Daoshi Technology announced an investment in Qiangna Technology through its subsidiary Hong Kong Qiana, aiming to enhance its "AI + new materials" strategy and capitalize on Qiangna's expertise in brain-computer interface technology [1][3][5]. Investment Details - Hong Kong Qiana plans to invest $30 million in Qiangna Technology's Pre-B round of preferred stock, acquiring minority shareholder rights [3]. - Qiangna Technology is valued at over $1.3 billion and is in discussions for potential IPO [3]. Company Background - Qiangna Technology, founded in 2015 by Han Bicheng during his PhD at Harvard, specializes in non-invasive brain-computer interface technology [4]. - The company is recognized as one of the "Six Little Dragons of Hangzhou" and has developed products like intelligent bionic hands and legs [4]. Strategic Intent - Daoshi Technology aims to leverage Qiangna's experience in medical rehabilitation, educational consumption, and human-computer interaction to enhance its "AI + new materials" ecosystem [5]. - The company is focused on integrating AI with materials innovation, having previously established partnerships and investments in the AI sector [5][6]. Ongoing Projects - Daoshi Technology is advancing its second-generation APU product through its subsidiary Chip Pei Sen, with applications in lithium batteries and semiconductors [6]. - The Guangdong Hexi Atomic Computing Center is a key platform for supporting the "AI + materials" strategy, focusing on high-speed computing for material research [6].